Navigation Links
Springer to publish new society journal in cardiology
Date:2/5/2008

Springer and the International Society for Cardiovascular Translational Research (ISCTR) are founding a new, quarterly biomedical publication called the Journal of Cardiovascular Translational Research (JCTR). The journal will be officially introduced at the Inaugural Meeting of the International Society for Cardiovascular Translational Research to be held 9 -10 February 2008 in San Diego, CA, USA. The first issue will be published in March 2008.

The Journal of Cardiovascular Translational Research will publish original papers in the areas of cellular therapy, genomics, personalized medicine and devices for the potential treatment of advanced cardiovascular disease. The aim of the journal is to provide outstanding peer-reviewed articles with implications for the current and future practice of clinical cardiovascular medicine. It will provide content in which translational research involving multiple disciplines such as genetics, proteomics, epidemiology and preclinical and clinical research is used interchangeably within a study to advance the understanding of disease or response to treatment. Editors-in-chief Nabil Dib of the University of California at San Diego and Jennifer L. Hall of the University of Minnesota are supported by outstanding executive and editorial boards.

Nabil Dib, MD, MSc, co-editor-in-chief of JCTR, said, Cardiovascular disease kills some 17 million people every year, which is one-third of all deaths worldwide. Groundbreaking developments in this area between biomedical research and clinical medicine necessitate a new platform for the exchange and dissemination of information. Springer, as an international STM publisher, is in a strong position to launch this new journal.

Aaron Johnson, Editor, Biomedical Engineering, Biotechnology and Genetics at Springer, said, Currently there is no journal in this field that provides a forum between bench and bedside. JCTR will fill this gap, presenting a critical overview of advances as they unfold. We are excited at the prospect of working with the ISCTR on this new journal, which can help to shape the future of cardiovascular research.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related medicine news :

1. Springer launches Springer Protocols
2. Springer publishes La Chirurgia degli Organi de Movimento
3. Springer founds new electronic journal Head and Neck Pathology
4. Springer launches new journal in musculoskeletal medicine
5. Springer to publish Sports Engineering
6. Springer adds Advances in Therapy to journals portfolio
7. VWR International Publishes New Laboratory Casework and Technical Furniture Catalog
8. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
9. Landmark Articles Published by QualityMetric Scientists Report Improvements in Short Form Health Status Measures and Establish Criteria for Future Development
10. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
11. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
Breaking Medicine Technology: